Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Saturday, February 24, 2018

Rehabilitation of Stroke Patients with Plegic Hands: Randomized Controlled Trial of Expanded Constraint-Induced Movement Therapy

Luckily my doctors didn't seem to know about CIMT, although a friend who was a PT there did know about it.   I would assume that severe upper extremity hemiparesis would disqualify from CIMT because you wouldn't have use of the hand at all. I guess I don't have an understanding of how you would expand CIMT. So because we don't have a public database of stroke protocols this will never get into wide dissemination to all stroke hospitals.
Rehabilitation of Stroke Patients with Plegic Hands: Randomized Controlled Trial of Expanded Constraint-Induced Movement Therapy
Gitendra USWATTEa,b, Edward TAUBa, Mary H. BOWMANa, Adriana DELGADOa, Camille BRYSONa, David M. MORRISb, Staci MCKAYa, Joydip BARMANa, Victor W. MARKa,c,d Departments of aPsychology, bPhysical Therapy, cPhysical Medicine & Rehabilitation, and dNeurology, University of Alabama at Birmingham (UAB), Birmingham, AL, USA

Corresponding Author:  Gitendra Uswatte, PhD, Department of Psychology, UAB, 1720 2nd Avenue S, STE CH415, Birmingham, AL, 35294, USA. Tel.:+1 205 975 5089; Fax: +1 205 975 6140; E-mail: guswatte@uab.edu.

Abstract.  Purpose: To evaluate the efficacy of an expanded form of Constraint-Induced Movement Therapy (eCIMT) that renders CIMT, originally designed for treating mild-to-moderate upper
extremity hemiparesis, suitable for treating severe hemiparesis.  Methods:  Twenty-one adults ≥1 year after stroke with severe upper-extremity hemiparesis (with little or no capacity to make movements with the more-affected hand) were randomly assigned to
eCIMT (n=10), a placebo-control procedure (n=4), or usual care (n=7). The participants who
received usual care were crossed over to eCIMT four months after enrollment. The CIMT
protocol was altered to include fitting of orthotics and assistive devices, selected
neurodevelopmental techniques, and electromyography-triggered functional electrical
stimulation. Treatment was given for 15 consecutive weekdays with 6 hours of therapy
Rehab of Severe Upper-limb Hemiparesis 2

scheduled daily for the immediate eCIMT group and 3.5 hours daily for the cross-over eCIMT
group.  Results:  At post-treatment, the immediate eCIMT group showed significant gains relative to the combination of the control groups on the Grade-4/5 Motor Activity Log (MAL; mean=1.5
points, P<0.001,  f=4.2) and a convergent measure, the Canadian Occupational Performance
Measure (COPM; mean=2.3, P=0.014,  f=1.1;  f values ≥0.4 are considered large, on the COPM
changes ≥2 are considered clinically meaningful). At 1-year follow-up, the MAL gains in the
immediate eCIMT group were only 13% less than at post-treatment. The short and long-term
outcomes of the crossover eCIMT group were similar to those of the immediate eCIMT group. Conclusions:  This small, randomized controlled trial (RCT) suggests that eCIMT produces a large, meaningful, and persistent improvement in everyday use of the more-affected arm in
adults with severe upper-extremity hemiparesis long after stroke
. These promising findings
warrant confirmation by a large RCT. 

No comments:

Post a Comment